Nuzenio

Expands Targeted Options

Expands Targeted Options news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

FDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA - mskcc.orgmskcc.org · Thu, 06 Aug 2026 04:00:00 GMT FDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies - Targeted OncologyTargeted Oncology · Tue, 04 Aug 2026 20:10:58 GMT New therapeutic target expands options for multiple myeloma - Penn TodayPenn Today · Tue, 04 Aug 2026 12:00:00 GMT ASCO Living Guideline Update Expands Targeted Options in Advanced NSCLC - Targeted OncologyTargeted Oncology · Mon, 03 Aug 2026 13:06:17 GMT Targeted Therapy Expands Into Adjuvant and Neoadjuvant Settings for Oncogene-Driven Early-Stage NSCLC - OncLiveOncLive · Wed, 29 Jul 2026 16:01:06 GMT Zenocutuzumab Expands Targeted Treatment Options for NRG1 Fusion-Positive Cholangiocarcinoma - HMP Global Learning NetworkHMP Global Learning Network · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 04:00:00 GMTFDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA - mskcc.org

Tue, 04 Aug 2026 20:10:58 GMTFDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies - Targeted Oncology

Tue, 04 Aug 2026 12:00:00 GMTNew therapeutic target expands options for multiple myeloma - Penn Today

Mon, 03 Aug 2026 13:06:17 GMTASCO Living Guideline Update Expands Targeted Options in Advanced NSCLC - Targeted Oncology

Wed, 29 Jul 2026 16:01:06 GMTTargeted Therapy Expands Into Adjuvant and Neoadjuvant Settings for Oncogene-Driven Early-Stage NSCLC - OncLive

Tue, 28 Jul 2026 07:00:00 GMTZenocutuzumab Expands Targeted Treatment Options for NRG1 Fusion-Positive Cholangiocarcinoma - HMP Global Learning Network

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

FDA Expands Approval2 live mentions Pluvicto2 live mentions Metastatic Prostate Cancer2 live mentions Targets2 live mentions Protein Called PSMA2 live mentions Expanding Options2 live mentions Oncology Targeted Oncology2 live mentions Neoadjuvant Settings2 live mentions Oncogene2 live mentions Driven Early2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Expands Targeted Options.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.